News

Enterprise Products Partners EPD is progressing on a major $6-billion portfolio of growth initiatives focused on bolstering its integrated midstream network and expanding U.S. hydrocarbon export

Advanced Micro Devices AMD shares have jumped 34% year to date (YTD), outperforming the Zacks Computer and Technology sector and its closest peers, NVIDIA NVDA and Intel INTC. The broader sector has

lululemon athletica inc. LULU reported second-quarter fiscal 2025 results, wherein earnings per share (EPS) beat the Zacks Consensus Estimate, while revenues lagged the same. The company’s top and

Zumiez Inc. ZUMZ reported second-quarter fiscal 2025 results, wherein the top line surpassed the Zacks Consensus Estimate and improved year over year. The bottom line beat the estimate and declined

Futu Holdings Limited FUTU reported a record year-over-year client asset surge of 68.1% and a sequential 17.4% rise as of the June quarter. The primary reason behind this outstanding growth was the

Although September has historically been one of the underperforming months for the stock market and can be prone to panic selling, this can create opportunities for seasoned investors or those

Investors in JD.com, Inc. JD need to pay close attention to the stock based on moves in the options market lately. That is because the Sept 19, 2025 $18.00 Call had some of the highest implied

ConocoPhillips COP is a U.S.-based upstream energy firm having a diversified portfolio of low-cost assets spread across 14 countries globally. The company, being primarily involved in the upstream

Zacks Investment Research has recently initiated coverage of United Security Bancshares UBFO with a Neutral recommendation, pointing to a balance between the bank’s strong capital profile and stable

A global professional services provider, Aon plc AON has announced its multi-year partnership deal as the official partner of Scuderia Ferrari HP, the most legendary and successful team of Formula

Affirm Holdings, Inc. AFRM has established a distinct position in the Buy Now, Pay Later (BNPL) space by placing underwriting at the core of its business strategies. The company has developed a

The S&P 500 has risen about 11% year to date and nearly 30% since rebounding in early April. After advancing 4.2% in August, the index has extended its momentum into September, making it a rewarding

Investors in Sprouts Farmers Market, Inc. SFM need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 16, 2025 $30.00 Call had some of the

GE Aerospace GE recently entered into a partnership and equity investment agreement with BETA Technologies Inc. (“BETA”), pending regulatory approval. The collaboration aims to advance the

The Coca-Cola Company KO is winning by leaning on its ability to balance global scale with sharp local execution. In second-quarter 2025, the company delivered 5% year-over-year organic revenue

Cheesecake Factory CAKE continues to benefit from multiple growth drivers, including expansion initiatives, strong operational execution and ongoing strategic innovation. Improvements in labor

Ulta Beauty, Inc. ULTA maintains its leadership in beauty retail by uniting mass, prestige and luxury products within a dynamic and inclusive shopping experience. The company's ability to generate

Shares of NextEra Energy NEE have gained 2.1% in the quarter-to-date period compared with the Zacks Utility - Electric Power industry’s rally of 1.8%.NextEra Energy’s solid operational performance

Energy Fuels UUUU is currently trading at a forward price-to-sales ratio of 26.00X, a significant premium to the non-ferrous mining industry’s 2.94X. 

UUUU’s Value Score of F suggests that the stock

Oracle’s ORCL NetSuite Cloud ERP has emerged as a major growth catalyst in its cloud strategy, driving strong growth across the applications segment. In the fourth quarter of fiscal 2025, NetSuite

SoundHound AI, Inc. SOUN is leaning into its Voice Commerce strategy, positioning the capability as the next growth engine across its automotive and restaurant customer base. Once a long-term

Aquestive Therapeutics AQST announced that the FDA has informed that no advisory committee meeting is required to discuss the new drug application (NDA) for AQST’s key product candidate, Anaphylm

Myriad Genetics, Inc. MYGN recently published results from a meta-analysis in the Journal of Clinical Psychopharmacology, stating the superiority of the company’s GeneSight Psychotropic test over